References
- Wisplinghoff H, Bischoff T, Tallent SM, Seifert H, Wenzel RP, Edmond MB. Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study. Clin Infect Dis 2004; 39: 309–17
- Edmond MB, Wallace SE, McClish DK, Pfaller MA, Jones RN, Wenzel RP. Nosocomial bloodstream infections in United States hospitals: a three-year analysis. Clin Infect Dis 1999; 29: 239–44
- Nguyen MH, Peacock JE, Jr, Tanner DC, Morris AJ, Nguyen ML, Snydman DR, et al. Therapeutic approaches in patients with candidemia. Evaluation in a multicenter, prospective, observational study. Arch Intern Med 1995; 155: 2429–35
- Reinhardt JF, Ruane PJ, Walker LJ, George WL. Intravenous catheter-associated fungemia due to Candida rugosa. J Clin Microbiol 1985; 22: 1056–7
- Colombo AL, Melo AS, Crespo Rosas RF, Salomão R, Briones M, Hollis RJ, et al. Outbreak of Candida rugosa candidemia: an emerging pathogen that may be refractory to amphotericin B therapy. Diagn Microbiol Infect Dis 2003; 46: 253–7
- Dubé MP, Heseltine PN, Rinaldi MG, Evans S, Zawacki B. Fungemia and colonization with nystatin-resistant Candida rugosa in a burn unit. Clin Infect Dis 1994; 18: 77–82
- Shenoy S, Samuga M, Urs S, Anuradha KM, Kurian MM, Augustine A, et al. Intravenous catheter-related Candida rugosa fungaemia. Trop Doct 1996; 26: 31
- Arisoy ES, Correa A, Seilheimer DK, Kaplan SL. Candida rugosa central venous catheter infection in a child. Pediatr Infect Dis J 1993; 12: 961–3
- Krcmery V, Jr, Mrazova M, Kunova A, Grey E, Mardiak J, Jurga L, et al. Nosocomial candidaemias due to species other than Candida albicans in cancer patients. Aetiology, risk factors, and outcome of 45 episodes within 10 years in a single cancer institution. Support Care Cancer 1999; 7: 428–31
- Hanzen J, Krcmery V. Polyfungal candidaemia due to Candida rugosa and Candida pelliculosa in a haemodialyzed neonate. Scand J Infect Dis 2002; 34: 555
- Kötting, J, Eibl, H. Lipases and phospholipases in organic synthesis. In: P Woolley, Petersen, SB. Lipases—their structure, biochemistry and application. CambridgeUK: Cambridge University Press; 1994. 289–313.
- Domínguez de María P, Sánchez-Montero JM, Sinisterra JV, Alcántara AR. Understanding Candida rugosa lipases: an overview. Biotechnol Adv 2006; 24: 180–96
- Crawshaw WM, MacDonald NR, Duncan G. Outbreak of Candida rugosa mastitis in a dairy herd after intramammary antibiotic treatment. Vet Rec 2005; 156: 812–3
- Jensen HE, Aalbaek B. Pathogenicity of yeasts and algae isolated from bovine mastitis secretions in a murine model. Mycoses 1994; 37: 101–7
- Pfaller MA, Diekema DJ, Colombo AL, Kibbler C, Ng KP, Gibbs DL, et al. Candida rugosa, an emerging fungal pathogen with resistance to azoles: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program. J Clin Microbiol 2006; 44: 3578–82
- Ostrosky-Zeichner L, Rex JH, Pappas PG, Hamill RJ, Larsen RA, Horowitz HW, et al. Antifungal susceptibility survey of bloodstream Candida isolates in the United States. Antimicrob Agents Chemother 2003; 47: 3149–54
- Pfaller MA, Diekema DJ. Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus. J Clin Microbiol 2004; 42: 4419–31
- Rosas, R, Nucci, M, Castelo, A, Colombo, AL. Predictive Value of Candida spp. Colonization in the Diagnosis of Candidemia in Intensive Care Unit (ICU) Patients (pts). Abstract M-269.WashingtonDC, USA, 2004